domingo, 18 de marzo de 2018

Hereditary Angioedema: The Economics of Treatment of an Orphan Disease. - PubMed - NCBI

Hereditary Angioedema: The Economics of Treatment of an Orphan Disease. - PubMed - NCBI



 2018 Feb 16;5:22. doi: 10.3389/fmed.2018.00022. eCollection 2018.

Hereditary Angioedema: The Economics of Treatment of an Orphan Disease.

Abstract

This review will discuss the cost burden of hereditary angioedema on patients, healthcare systems, and society. The impact of availability of and access to novel and specific therapies on morbidity, mortality, and the overall burden of disease will be explored along with potential changes in treatment paradigms to improve effectiveness and reduce cost of treatment. The prevalence of orphan diseases, legislative incentives to encourage development of orphan disease therapies and the impact of orphan disease treatment on healthcare payment systems will be discussed.

KEYWORDS:

burden; health economics; hereditary angioedema; orphan disease; treatment

PMID:
 
29503818
 
PMCID:
 
PMC5820358
 
DOI:
 
10.3389/fmed.2018.00022

No hay comentarios: